摘要
新型冠状病毒(简称“新冠病毒”)奥密克戎变异株感染恢复期患者心悸高发且普遍伴有气虚症状。分析其病机,首先,因疫疠之毒暴伤人体,正气急性亏虚,三焦元气受损致营气、卫气、宗气化生不及,心、肺气阴耗伤,瘀血内停,胸中大气下陷,气机滞碍,心失所养,瘀阻心络。其次,过汗伤正、阴阳失调也会导致心悸。再次,气虚湿阻、余邪未尽也是引发心悸的病机。新冠病毒奥密克戎变异株感染恢复期引发的心悸须针对病机治疗,以扶正祛邪为主,治以益气养阴、补气升提、活血化瘀,余邪未尽者辅以透邪祛湿。
Patients infected with SARS-CoV-2 Omicron,referred to as a pathogenic toxin in traditional Chinese medicine(TCM),in the convalescent period suffer from a high incidence of palpitations and generally present TCM patterns of qi deficiency.The main pathogenic mechanisms are that(i)the toxin of plague severely injured the human body,resulting in acute deficiency of vital qi;(ii)the damage of sanjiao(a TCM term)energy resulted in the deficiency of producing nutrient qi,defensive qi,and pectoral qi;and(iii)the qi and yin of heart and lung were drained,leading to internal blockade of blood stasis,qi collapse in the chest,qi obstruction,malnutrition of heart blood,and static blood blocking the hear collateral.There is also the pathogenesis of palpitations caused by excessive sweating and disharmony of yin and yang.Furthermore,some COVID-19 patients with palpitations in the convalescent period suffer from qi deficiency inducing dampness obstruction and lingering remnant pathogen.Treatment of symptoms related to palpitations caused by SARS-CoV-2 Omicron should focus on strengthening vital qi to eliminate the pathogenic factor,including benefiting qi and nourishing yin,invigorating qi for ascending,and promoting blood circulation for removing blood stasis,while diffusing pathogen and removing dampness in the condition of lingering remnant pathogen.
作者
傅骞
姜良铎
FU Qian;JIANG Liangduo(Hangzhou TCM Hospital Affiliated to Zhejiang Chinese Medical University,Hangzhou 310006,China;Dongzhimen Hospital,Beijing University of Chinese Medicine,Beijing 100700,China)
出处
《北京中医药大学学报》
CAS
CSCD
北大核心
2023年第7期965-969,共5页
Journal of Beijing University of Traditional Chinese Medicine
基金
国家重点研发计划项目(No.2018YFC1704106)
杭州市生物医药和健康产业发展扶持科技专项(No.2021WJCY205)。
关键词
新型冠状病毒
奥密克戎变异株
恢复期
心悸
病机
治疗
SARS-CoV-2
Omicron variant
convalescent period
palpitation
pathogenesis
treatment